Comparative Study of NXL103 Versus Comparator in Adults With Community Acquired Pneumonia

• Status: Completed
• Trial end date: 2008-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the efficacy, safety and tolerance of 2 different dose levels of oral NXL103 with oral comparator in the treatment of community acquired pneumonia in adults

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novexel Inc
• Treatments: Streptogramin A

Criteria

Inclusion Criteria:

• Community acquired pneumonia

Exclusion Criteria:

• severe CAP

• respiratory infections attributed to sources other than community acquired bacterial infection

• concomitant pulmonary disease

• history of hypersensitivity to study medication, macrolide or beta lactam antibiotics